Announcements Trials

Browse Landscape

Phase

Phase 1 6 Phase 2 3 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 60 Prostatic Neoplasms 52 Squamous Cell Carcinoma of Head and Neck 43 Carcinoma, Non-Small-Cell Lung 39 Head and Neck Neoplasms 37 Lung Neoplasms 35 Lymphoma 34 Leukemia 22 Brain Neoplasms 20 Central Nervous System Neoplasms 19 Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Glioblastoma 18 Uterine Cervical Neoplasms 17 Sarcoma 17 Rectal Neoplasms 17 Lymphoma, Follicular 16 Esophageal Squamous Cell Carcinoma 16 Esophageal Neoplasms 15 Lymphoma, Large B-Cell, Diffuse 14 Hodgkin Disease 14 Burkitt Lymphoma 14 Adenocarcinoma of Lung 13 Oligodendroglioma 12 Lymphoma, Non-Hodgkin 12 Neoplasm Metastasis 11 Astrocytoma 11 Rhabdomyosarcoma 10 Lymphoma, Large-Cell, Immunoblastic 10 Neuroblastoma 9 Nasopharyngeal Carcinoma 9

Interventions

Temozolomide 2 Valproic Acid 1 TIC10 compound 1 Radiotherapy 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Diffuse Intrinsic Pontine Glioma × Radiotherapy × Clear all

NCT05476939 2026-02-05

BIOMEDE 2

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Recruiting

Diffuse Intrinsic Pontine Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡